BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35892820)

  • 1. Cancer Cell Metabolism Reprogramming and Its Potential Implications on Therapy in Squamous Cell Carcinoma of the Head and Neck: A Review.
    Perri F; Della Vittoria Scarpati G; Pontone M; Marciano ML; Ottaiano A; Cascella M; Sabbatino F; Guida A; Santorsola M; Maiolino P; Cavalcanti E; Togo G; Ionna F; Caponigro F
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hallmarks of cancer: the next generation.
    Hanahan D; Weinberg RA
    Cell; 2011 Mar; 144(5):646-74. PubMed ID: 21376230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical Exercise and the Hallmarks of Breast Cancer: A Narrative Review.
    García-Chico C; López-Ortiz S; Peñín-Grandes S; Pinto-Fraga J; Valenzuela PL; Emanuele E; Ceci C; Graziani G; Fiuza-Luces C; Lista S; Lucia A; Santos-Lozano A
    Cancers (Basel); 2023 Jan; 15(1):. PubMed ID: 36612320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma.
    Sasahira T; Kirita T
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30115834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rho GTPases modulate malignant transformation of tumor cells.
    Orgaz JL; Herraiz C; Sanz-Moreno V
    Small GTPases; 2014; 5():e29019. PubMed ID: 25036871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity: a perfect storm for carcinogenesis.
    Harris BHL; Macaulay VM; Harris DA; Klenerman P; Karpe F; Lord SR; Harris AL; Buffa FM
    Cancer Metastasis Rev; 2022 Sep; 41(3):491-515. PubMed ID: 36038791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic signature of squamous cell carcinoma of the head and neck: Consequences of TP53 mutation and therapeutic perspectives.
    Wilkie MD; Lau AS; Vlatkovic N; Jones TM; Boyd MT
    Oral Oncol; 2018 Aug; 83():1-10. PubMed ID: 30098763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-stroma crosstalk: targeting stroma in breast cancer.
    Criscitiello C; Esposito A; Curigliano G
    Curr Opin Oncol; 2014 Nov; 26(6):551-5. PubMed ID: 25279962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between fatty acid metabolism and tumour-associated macrophages in cancer progression.
    Zaidi NE; Shazali NAH; Leow TC; Osman MA; Ibrahim K; Rahman NMANA
    Biomedicine (Taipei); 2022; 12(4):9-19. PubMed ID: 36816174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNAs in cancer: Another layer of complexity.
    de Oliveira JC; Oliveira LC; Mathias C; Pedroso GA; Lemos DS; Salviano-Silva A; Jucoski TS; Lobo-Alves SC; Zambalde EP; Cipolla GA; Gradia DF
    J Gene Med; 2019 Jan; 21(1):e3065. PubMed ID: 30549380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle Based Combination Treatments for Targeting Multiple Hallmarks of Cancer.
    VanDyke D; Kyriacopulos P; Yassini B; Wright A; Burkhart E; Jacek S; Pratt M; Peterson CR; Rai P
    Int J Nano Stud Technol; 2016; Suppl 4():1-18. PubMed ID: 27547592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fighting Carcinogenesis with Plant Metabolites by Weakening Proliferative Signaling and Disabling Replicative Immortality Networks of Rapidly Dividing and Invading Cancerous Cells.
    Wani AK; Akhtar N; Sharma A; El-Zahaby SA
    Curr Drug Deliv; 2023; 20(4):371-386. PubMed ID: 35422214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural products as potential cancer therapy enhancers: A preclinical update.
    Agbarya A; Ruimi N; Epelbaum R; Ben-Arye E; Mahajna J
    SAGE Open Med; 2014; 2():2050312114546924. PubMed ID: 26770737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant sialylation in ovarian cancers.
    Lee WL; Wang PH
    J Chin Med Assoc; 2020 Apr; 83(4):337-344. PubMed ID: 31904658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact.
    Mountzios G; Rampias T; Psyrri A
    Ann Oncol; 2014 Oct; 25(10):1889-1900. PubMed ID: 24718888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Pyk2 in the CCR7-mediated regulation of metastasis and viability in squamous cell carcinoma of the head and neck cells in vivo and in vitro.
    Yue Y; Li ZN; Fang QG; Zhang X; Yang LL; Sun CF; Liu FY
    Oncol Rep; 2015 Dec; 34(6):3280-7. PubMed ID: 26352169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metadherin regulation of vascular endothelial growth factor expression is dependent upon the PI3K/Akt pathway in squamous cell carcinoma of the head and neck.
    Zhu GC; Yu CY; She L; Tan HL; Li G; Ren SL; Su ZW; Wei M; Huang DH; Tian YQ; Su RN; Liu Y; Zhang X
    Medicine (Baltimore); 2015 Feb; 94(6):e502. PubMed ID: 25674742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caregivers with Cancer Patients: Focus on Hispanics.
    Bisht J; Rawat P; Sehar U; Reddy PH
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck.
    Chikamatsu K; Ishii H; Murata T; Sakakura K; Shino M; Toyoda M; Takahashi K; Masuyama K
    Cancer Sci; 2013 Nov; 104(11):1468-75. PubMed ID: 23992541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour metabolism in squamous cell carcinoma of the head and neck: an in-vitro study of the consequences of TP53 mutation and therapeutic implications.
    Wilkie M; Lau A; Vlatkovic N; Jones T; Boyd M
    Lancet; 2015 Feb; 385 Suppl 1():S101. PubMed ID: 26312831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.